» Articles » PMID: 11030148

Activation of the Alpha2beta1 Integrin Prevents C-erbB2-induced Scattering and Apoptosis of Human Mammary Epithelial Cells in Collagen

Overview
Journal Oncogene
Date 2000 Oct 13
PMID 11030148
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Constitutive overexpression of c-erbB2 in the mammary epithelial cell line MTSV1-7 has been shown to result in epithelial-mesenchymal conversion, anchorage-independent growth and loss of organized morphogenesis in collagen. To elucidate the events leading to this drastic change, MTSV1-7 cells and its subclone HB2 (which shows a more strictly epithelial phenotype) were transfected with the hybrid trk-neu receptor consisting of the extracellular domain of the trkA nerve growth factor (NGF) receptor and the transmembrane and cytoplasmic domains of c-erbB2 (neu). In cells expressing this construct, c-erbB2 homodimerization can be mimicked by addition of NGF. In trk-neu transfectants of HB2 cells, modest expression led to increased cell proliferation upon NGF treatment. When clones with higher expression levels were grown in collagen, NGF instead induced cell scattering, diminished viability and dramatically increased apoptosis. Interestingly, both the dissociation of colonies and loss of cell viability could be completely reversed by treatment of the cells with antibodies that activate the adhesive capacity of the alpha2beta1 integrin. Long-term NGF treatment of high-expressing transfectants generated fibroblastic clones displaying a reduced expression of integrin alpha2 and E-cadherin, and extensive apoptosis in collagen. These results, which indicate that strong c-erbB2 signalling may lead to downregulation and/or inactivation of the alpha2beta1 integrin, promoting apoptosis in collagen, provide one possible explanation to the increased apoptosis frequently seen in early tumour development.

Citing Articles

Integrin α2 in the microenvironment and the tumor compartment of digestive (gastrointestinal) cancers: emerging regulators and therapeutic opportunities.

Liu T, Gu Y, Zhang Y, Li Y Front Oncol. 2024; 14:1439709.

PMID: 39568561 PMC: 11576383. DOI: 10.3389/fonc.2024.1439709.


Loss of E-cadherin expression is not a prerequisite for c-erbB2-induced epithelial-mesenchymal transition.

Nilsson G, Akhtar N, Kannius-Janson M, Baeckstrom D Int J Oncol. 2014; 45(1):82-94.

PMID: 24807161 PMC: 4079157. DOI: 10.3892/ijo.2014.2424.


Cytogenetic characterization of HB2 epithelial cells from the human breast.

Caradonna F, Luparello C In Vitro Cell Dev Biol Anim. 2013; 50(1):48-55.

PMID: 23982912 DOI: 10.1007/s11626-013-9676-3.


ErbB/integrin signaling interactions in regulation of myocardial cell-cell and cell-matrix interactions.

Pentassuglia L, Sawyer D Biochim Biophys Acta. 2012; 1833(4):909-16.

PMID: 23261977 PMC: 8984683. DOI: 10.1016/j.bbamcr.2012.12.007.


Zinc finger transcription factors designed for bispecific coregulation of ErbB2 and ErbB3 receptors: insights into ErbB receptor biology.

Lund C, Popkov M, Magnenat L, Barbas 3rd C Mol Cell Biol. 2005; 25(20):9082-91.

PMID: 16199884 PMC: 1265768. DOI: 10.1128/MCB.25.20.9082-9091.2005.